Groundbreaking treatments and vaccines offer hope in fight against cancer
There have been several promising developments lately in cancer research and treatment, including a new drug approved by the FDA this week for advanced pancreatic cancer. William Brangham reports.
Recent breakthroughs in cancer research have brought hope to the field, with the approval of a new drug for advanced pancreatic cancer and the development of an individualized vaccine for melanoma patients. Pancreatic cancer, notoriously difficult to treat, has a dismal five-year survival rate of 13 percent. The new pill, daraxonib, nearly doubles patient survival time while minimizing severe side effects.
Dr. Robert Vonderheide, director of the Abramson Center at Penn Medicine, expressed optimism about the drug's potential to impact patient outcomes and reverse existing statistics. The vaccine targets melanoma patients in remission, lowering the risk of relapse by enhancing the immune system's response to cancer-specific mutations.
While the vaccine is not yet FDA-approved, early results from clinical trials are promising. Dr. Vonderheide anticipates more advancements in cancer vaccines as the technology continues to evolve.
Written by urgent.news from PBS NewsHour's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
